+485.5%
CIFR vs THC
+244.5%
+241.0%
-71.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.1% | +0.6% | +1.5% | +2.1% |
| 7D | +16.9% | -0.7% | +17.6% | +17.0% |
| 30D | -5.2% | +1.3% | -6.4% | -5.5% |
| 3M | -30.6% | +64.2% | -94.8% | -37.7% |
| 6M | +10.6% | +8.3% | +2.3% | +9.1% |
| YTD | +20.2% | +33.4% | -13.2% | +13.0% |
| 1Y | +139.7% | +37.7% | +102.1% | +124.0% |
| All | +485.5% | +244.5% | +241.0% | +231.1% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling